scispace - formally typeset
A

Andrew A. Kanner

Researcher at Rabin Medical Center

Publications -  59
Citations -  6819

Andrew A. Kanner is an academic researcher from Rabin Medical Center. The author has contributed to research in topics: Temozolomide & Radiosurgery. The author has an hindex of 28, co-authored 57 publications receiving 5469 citations. Previous affiliations of Andrew A. Kanner include Tel Aviv University & Tel Aviv Sourasky Medical Center.

Papers
More filters
Journal ArticleDOI

Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial

TL;DR: In the final analysis of this randomized clinical trial of patients with glioblastoma who had received standard radiochemotherapy, the addition of TTFields to maintenance temozolomide chemotherapy vs maintenance Temozolmide alone, resulted in statistically significant improvement in progression-free survival and overall survival.
Journal ArticleDOI

NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality

TL;DR: No improvement in overall survival was demonstrated, however efficacy and activity with this chemotherapy-free treatment device appears comparable to chemotherapy regimens that are commonly used for recurrent glioblastoma.